Pharmacological fMRI--challenges in analysing drug-induced single-event BOLD responses

Andreas Pohlmann1, Hervé Barjat, Lorna C Tilling

  • 1Neurology & GI Centre of Excellence in Drug Discovery, GlaxoSmithKline R&D Ltd., Harlow, CM19 5AW, UK. andreas.x.pohlmann@gsk.com

Related Concept Videos